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Abstract
Background: Previous research has shown positive effects of music therapy for people with
schizophrenia and other mental disorders. In clinical practice, music therapy is often offered to
psychiatric patients with low therapy motivation, but little research exists about this population.
The aim of this study is to examine whether resource-oriented music therapy helps psychiatric
patients with low therapy motivation to improve negative symptoms and other health-related
outcomes. An additional aim of the study is to examine the mechanisms of change through music
therapy.
Methods: 144 adults with a non-organic mental disorder (ICD-10: F1 to F6) who have low therapy
motivation and a willingness to work with music will be randomly assigned to an experimental or
a control condition. All participants will receive standard care, and the experimental group will in
addition be offered biweekly sessions of music therapy over a period of three months. Outcomes
will be measured by a blind assessor before and 1, 3, and 9 months after randomisation.
Discussion: The findings to be expected from this study will fill an important gap in the knowledge
of treatment effects for a patient group that does not easily benefit from treatment. The study's
close link to clinical practice, as well as its size and comprehensiveness, will make its results well
generalisable to clinical practice.
Background
Music therapy is defined as a systematic process where the
therapist helps the client to promote health, using musical
experiences and the relationships that develop through
them [1]. It is often perceived as a psychotherapeutic
method where musical interaction, in addition to verbal
discussion, is used as a means of communication and
expression. The aim of music therapy is to help people
with mental health problems to develop relationships
and to address issues they may not be able to by using
words alone. Results from a Cochrane review showed that
music therapy helps people with schizophrenia to
improve their global state, mental state and social func-
tioning in the short to medium term [2]. The review sug-
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gested that there is a need for studies examining the effects
of music therapy over a longer term. Furthermore, studies
are needed to examine the effectiveness of music therapy
in clinical practice, and to further explore the psychologi-
cal 'mechanisms' through which music therapy works.
Music therapy is usually not tailored to a specific diagno-
sis. Rather, contents of therapy are negotiated with the
patient within the process of therapy, based on a variety of
individual traits. It has been suggested that factors unre-
lated to psychiatric diagnosis, specifically therapy motiva-
tion, be considered when specifying, prescribing, and
evaluating psychotherapy [3]. Psychotherapy may not
work if patients are not motivated for it [4-6]. In music
therapy, the use of music (i.e. playing or listening to
music) itself can often be a motivating factor for patients
who may otherwise not be motivated for psychotherapy
[7]. Therefore, a low motivation for (other) therapy can
become a reason for referral of a patient to music therapy,
and such factors may at times be more important than the
patient's primary diagnosis. However, there is a scarcity of
research addressing the effects of music therapy for
patients with low therapy motivation. We found only one
randomised study on music therapy for depression where
the authors described that the majority of the participants
had previously failed to respond to verbal psychotherapy
[8].
The problem of low motivation may sometimes be due to
a lack of insight and will often lead to poor therapy out-
come. It has been described for a variety of disorders,
including schizophrenia [9-12], depression and bipolar
disorder [11,13], and psychosomatic disorders [14,15].
Music therapy is often recommended for such patients
and may have something unique to offer which is worth
exploring. A randomised study is needed to examine the
potential of music therapy for this under-researched but
clinically important population.
Resource-oriented music therapy for people with mental
health problems is oriented towards the client's resources,
strengths and potentials, rather than primarily on prob-
lems and conflicts, and emphasizes collaboration and
equal relationships [16,17]. Such a perspective to music
therapy builds on a contextual understanding of thera-
peutic processes [6,18,19], the philosophy of empower-
ment [20,21], and positive psychology [22]. In music
therapy, music may be seen as a central resource for the
patient, but a resource-oriented approach will also
emphasise the patient's resources in the verbal discussions
taking place within the music therapy sessions [17]. Goals
of resource-oriented music therapy with people with men-
tal health problems include, among others, the ability to
feel and express emotions, to build and sustain relation-
ships to others, and to develop interest and motivation.
Therefore the goals of the therapy are closely related to
what has been described as negative symptoms in mental
health research [2,23].
Objectives
The objectives of this study are as follows:
1.) To determine whether resource-oriented music ther-
apy helps psychiatric patients who have a low therapy
motivation and a willingness to work with music to
reduce their level of negative symptoms (primary study
outcome).
2.) To determine whether the therapy helps the patients to
improve in the following secondary outcomes:
(a) secondary outcomes of general relevance for the
patient: general symptoms; general functioning; clinical
global impressions.
(b) secondary outcomes specifically linked to the
assumed mechanisms of the therapy: interest in music;
motivation for change; self-efficacy; self-esteem; vitality;
affect regulation; relational competence; actual social rela-
tionships.
3.) Provided that significant effects are found: To deter-




The study will include adult patients with mental disor-
ders who have a low motivation for therapy, as specified
below. Criteria for in- and exclusion will be assessed by
the ward psychiatrist, based on information collected by
the clinical team on the ward.
Inclusion criteria
(a) Diagnosis F1 to F6
Participants must have a non-organic mental disorder (F1
to F6 according to ICD-10), as assessed by a psychiatrist at
a participating centre. The inclusion of such a broad range
of mental disorders is based on the finding that mecha-
nisms of psychotherapy are not specifically linked to diag-
nosis [6]. This broad range of diagnoses will also improve
external validity, which is often not optimal in ran-
domised trials which have too narrow inclusion criteria
[24].
(b) Low therapy motivation
This is the main inclusion criterion for the study. Patients
are often referred to music therapy because they have a
low therapy motivation and music can be motivating for
them. The specific reasons for this low therapy motivationBMC Psychiatry 2005, 5:39 http://www.biomedcentral.com/1471-244X/5/39
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may vary. Some patients may have insufficient insight
into having a mental health problem. Others may have
insight about having a problem but fail to acknowledge
psychosocial components. These patients may demand a
'medication cure' and state that they do not believe in
talking. Other patients may state that they do not feel
comfortable with talking about emotions and personal
problems. Patients may also have low therapy motivation
because they did not improve from therapy previously.
(c) Willingness to work with music
Participants will be included if they show a willingness to
work with music in music therapy. They do not need to
have an established interest in music, such as having
learnt an instrument or enjoying listening to music,
although this may be the case for some of them.
Exclusion criteria
(a) Severe mental retardation
The outcome measures include some self-reports and
therefore participants who are unable to complete these
cannot be included. Participants need to be cognitively
able to complete a self-report questionnaire.
(b) Severe life-threatening somatic illness
Participants with a severe life-threatening somatic illness
will not be included because the dynamics of such illness
would have such a strong influence on the course of ther-
apy that it would be highly questionable to pool them
with other patients.
Interventions
Participants will be randomly assigned to two groups
(details in next section). The interventions for both
groups will be provided and monitored over the course of
three months from randomisation.
Experimental group
(a) Music therapy
Participants assigned to the experimental group will
receive individual sessions of resource-oriented music
therapy. Two sessions per week will be offered, lasting
each 45 minutes. Over the course of three months this cor-
responds to a maximum of 26 sessions. Previous research
suggests that at least about 20 sessions are needed for
music therapy to have an effect [2]. In cases where it is not
possible to provide the maximum number of sessions,
therapists should try to ensure that at least 18 sessions will
be given within the three-month period. This may be the
case when outpatients live too far from the centre to
attend two times per week throughout the study period.
Music therapy will be provided in accordance with the
principles of resource-oriented music therapy [16,17].
These principles describe general therapeutic attitudes
and behaviours (e.g. focusing on the client's strengths and
potentials) as well as specific attitudes within the musical
interaction (e.g. tuning into the client's musical expres-
sion). Attitudes that should be avoided are also described,
as well as attitudes that are acceptable but not necessary.
Adherence to these principles and competence in their
application [16,17,25] will be monitored in two ways.
Therapists will rate their own behaviour at the end of
every session. This is an efficient way of monitoring the
complete course of therapy. To control for a possible sub-
jective bias in these self-reports, randomly selected ses-
sions will be videotaped and the therapist's adherence and
competence will be assessed by independent raters. Half
of all participants in the experimental group will be ran-
domly selected for videotaping of one therapy session
which will also be selected randomly.
(b) Standard care
Patients will continue to receive treatment as usual while
receiving music therapy. What kind and what dose or fre-
quency of other treatment they receive will be monitored




Patients will receive treatment as usual during the three-
month study period. What kind and what dose or fre-
quency of treatment they receive will be monitored by the
ward clinician before randomisation and after 1, 3, and 9
months.
(b) After the study period: Optional music therapy
For ethical reasons and in order to keep participants in the
control group motivated, they will be offered music ther-
apy after the three-month study period. Setting (i.e. indi-
vidual or group), frequency and duration need not be
equivalent to the experimental therapy, but will be set
according to clinical needs and possibilities. Adherence
and competence will not be monitored.
Study design
The study will use a single-blind (assessor blinded) ran-
domised design with two parallel groups of equal size.
Outcomes will be assessed at pretest (directly after inclu-
sion, before randomisation), at an early intermediate time
point (1 month after randomisation), posttest (3 months
after randomisation), and six-month follow-up (9
months after randomisation).
The required sample size was calculated for the primary
outcome, negative symptoms. We assumed an effect size
slightly smaller than medium (f = 0.20, equivalent to d =
0.40), based on the results of our Cochrane Review [2].
For a one-way ANCOVA with one covariate (pretest val-BMC Psychiatry 2005, 5:39 http://www.biomedcentral.com/1471-244X/5/39
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Flow chart of the study design Figure 1
Flow chart of the study design. Abbreviations: C – ward clinician; M – music therapist; I – principal investigator; A – blind 
assessor; MT – music therapy.
no
first contact with music therapist:
agreement to participate in the study?
(written informed consent) (M)
yes
obtain information on current treatment
and current diagnosis (C);







2 individual 45-min. sessions/week (M)
plus standard care
continue for 3 months
standard care
no music therapy
continue for 3 months
assessment of treatment fidelity:
1. after every session: therapist self-
rating (M)
2. randomly selected (I) time points and
patients: video observation (M) (max.
once per patient)
after 1 month (intermediate) and after 3 months (posttest): obtain information on treatment
received and current diagnosis (C); blind assessments, patient self-reports (A)
after 9 months (follow-up): obtain information on treatment received and current diagnosis (C);
blind assessments, patient self-reports (A)
randomise (I) - continue until N = 144
after 3 months: stop MT (M); continue
standard care
after 3 months: group or individual MT may
begin if desired (M); continue standard care
all adult psychiatric patients at participating hospitals with
-F 1t oF 6d i a g n o s i s
- low therapy motivation
- willingness to work with music
- no severe mental retardation
- no life-threatening somatic illness
reported, but not
followed upBMC Psychiatry 2005, 5:39 http://www.biomedcentral.com/1471-244X/5/39
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ues), α = 0.05, 80% power, and 36% variance explained
by the covariate, the required sample size available for
analysis (total number of valid cases) needs to be N = 2 *
65 = 130. In order to allow for 10% drop-outs, the total
sample size will need to be N = 144. The actual power of
the study may then be greater than 80% because of the
additional intermediate assessment points [26].
After inclusion in the study and pretest assessment, the
participants will be allocated to conditions using a com-
puterised randomisation procedure, stratified by treat-
ment centre and type of disorder (psychotic versus non-
psychotic). This will be done by the principal investigator
who has no direct contact to the patients in order to con-
ceal the allocation from the involved clinicians. An over-
view of the study design is shown in Figure 1.
The following professionals will be involved in conduct-
ing the study and collecting data:
1. Ward clinician (C): the clinician who has the primary
responsibility for the patient at the hospital unit.
2. Music therapists (M): academically qualified music
therapists with clinical experience in music therapy in psy-
chiatry and specifically trained in the use of the treatment
principles for resource-oriented music therapy.
3. Principal investigator (I): The first author (CG).
4. Blind assessor (A): an experienced clinician who is not
involved in the daily work at the patient's ward/hospital
unit and therefore not aware of the patient's assigned
treatment condition. The assessor will have received train-
ing in the use of the assessment instruments and will con-
duct a one-hour patient interview for each assessment.
The success of blinding is verified with a separate question
in the blind assessor questionnaire.
5. A local co-ordinator will help with the administrative
side of the data collection. This person will supervise and
facilitate the data collection process and ensure the relia-
ble and timely transferral of information between hospi-
tal staff and principal investigator.
6. Other music therapists will assess treatment fidelity
(adherence and competence) on the basis of the video
recordings.
Outcomes
The study will use blind ratings as well as self-reports.
Standardised instruments with demonstrated validity,
reliability and sensitivity to change will be applied when-
ever possible.
Primary outcome: Negative symptoms
The concept of negative symptoms has originally been
developed mainly in relation to psychotic disorders but is
considered relevant for other mental disorders as well
[27,28]. Including affective flattening and blunting, poor
social interaction and lack of interest, among others, it is
reasonable to assume that processes within music therapy
are directly linked to negative symptoms [2]. This out-
come will be evaluated by a trained blind assessor using
the Scale for the Assessment of Negative Symptoms
(SANS) composite score [23]. Validity of the SANS scale
has been demonstrated for a variety of mental disorders
[27,28]. Interrater reliability, test-retest reliability, internal
consistency and sensitivity to change following music
therapy have been demonstrated for schizophrenic
patients. In order to achieve reliable ratings, the assessor
must be trained in the use of this scale.
Secondary outcomes of general relevance for the patient
• General symptom level will be assessed using the BSI-18
self-report scale with 18 items addressing anxiety, depres-
sion, and somatic complaints [29]. It has demonstrated
concurrent and predictive validity as well as internal con-
sistency in clinical and community samples.
• General functioning will be measured using a blind rating
with the GAF [30]. The GAF is a widely used single-item
scale which has demonstrated good predictive validity
and interrater reliability.
• Global clinical impressions will also be evaluated by a
blind assessor using the CGI scale [31]. It consists of two
items and has been widely used to assess treatment out-
comes in mental health because of its simplicity and intu-
itiveness.
Secondary outcomes specifically linked to the assumed mechanisms 
of music therapy
• Interest in music: We were unable to find a published
scale that was appropriate for this outcome. Therefore we
developed a self-report scale to measure interest in music.
The scale has 11 Likert-scaled items assessing preferences
for various uses of music, actual behaviours, and emo-
tional responses to music. The scale is face-valid; its relia-
bility will be determined from the study sample.
• Motivation for change will be measured using a modified
version of the two URICA subscales precontemplation
and contemplation [32,33]. Predictive validity, reliability,
and sensitivity for change of this scale have been shown
for a variety of mental disorders [34,35]. The scale
includes 19 items. It will be used as a straightforward con-
tinuous measure in order to avoid the conceptual prob-
lems that are associated with the stages of change model
[36]. In addition to this self-report instrument, a blindedBMC Psychiatry 2005, 5:39 http://www.biomedcentral.com/1471-244X/5/39
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assessment of the patients' general motivation will be
included in the SANS avolition/apathy scale [23].
• Self-efficacy will be assessed using the modified Norwe-
gian version of the General Perceived Self-Efficacy Scale
[37]. This is a self-report measure with 10 Likert-scaled
items that has demonstrated test-retest reliability and
internal consistency in both clinical and non-clinical sam-
ples.
• Self-esteem will be measured using the Rosenberg Self-
Esteem Scale [38], a self-report measure with 10 items.
The scale has been used in many studies. Discriminant
validity, test-retest reliability and internal consistency
have been shown for patients with mental disorders.
• Vitality will be assessed using the vitality subscale of the
SF-36 scale [39]. This is a self-report scale with 4 items. It
has demonstrated discriminant validity and sensitivity to
change in schizophrenic patients, and internal consist-
ency and test-retest reliability have also been confirmed.
• Affect regulation will be measured with a blind rating
using the SANS subscale affecting flattening and blunting
[23]. The seven-item scale has good internal consistency.
Interrater reliability is moderate. Sensitivity to change fol-
lowing music therapy has been demonstrated in schizo-
phrenic patients.
• Relational competence will be assessed using the IIP-32
[40]. This self-report scale contains 32 items describing a
variety of interpersonal problems. It has demonstrated
internal consistency in psychotherapy patients and test-
retest reliability in a non-clinical sample.
• Actual social relationships will be measured using both a
self-report and a blinded assessment. The Q-LES-Q social
relationships subscale [41] will be used in self-reports. It
has 11 face-valid items and has demonstrated sensitivity
to change, test-retest reliability and internal consistency in
major depression. In addition, the blind assessor will
complete the SANS anhedonia/asociality subscale [23].
The 5-item scale has demonstrated satisfactory interrater
reliability, internal consistency, and sensitivity to change
following music therapy in schizophrenic patients.
In total, the self-report questionnaire will consist of 114
items. The blind assessor will check the completed ques-
tionnaire for completeness and help the patient if neces-
sary. The blind assessor questionnaire will consist of 28
items to be rated on the basis of a 1-hour clinical inter-
view.
Statistical analyses
The effects of treatment (Objectives 1 and 2) will be ana-
lysed using analysis of covariance methods and effect sizes
with confidence intervals. Subgroup analyses are planned
for psychotic versus non-psychotic disorders. No stopping
rules or interim analyses are planned for this study. The
primary analysis will be intention-to-treat.
Mediational processes (Objective 3) will be examined
using structural equation modelling [42,43], which will
address mediation of simultaneous as well as of subse-
quent change. Factor analysis will be used to examine
structures in the adherence and competence ratings.
Ethical issues
The study has been approved by the Regional Committees
for Medical Research Ethics Western Norway (REK Vest).
Time scale
The overall time frame for this project is from January
2004 to December 2007. Data collection is scheduled
from April 2005 to June 2007, and we expect to be able to
report the study's main results by December 2007.
Discussion
Relevance of the expected findings
The findings that can be expected from this study will be
highly relevant because of its size and comprehensiveness
and because of its close link to clinical practice. This study
will have a much greater sample size than all previous
studies on music therapy in the field of psychiatry to date.
This will enable a more precise estimation of the effect of
music therapy. The study will also be more comprehen-
sive than previous studies in terms of how the treatment
is defined and treatment fidelity measured, and in terms
of the inclusion of potential mediator variables. This com-
prehensiveness will allow an evaluation of the processes
and mechanisms leading to therapeutic change at a
greater level of detail than in previous studies in the field.
The close link to clinical practice will be ensured through
the application of the flexible therapy manual, but also
through the choice of the study population. The inclusion
criteria for this study define a population that is often
being referred to music therapy, and one that is in need of
special attention. The results of the study will therefore be
well generalisable to and relevant for clinical practice.
Limitations
The main limitations of this study will include the lack of
an alternative or 'placebo' therapy, the partial reliance on
self-reports, and the broadness of the sample. Due to the
lack of a placebo therapy, it could be argued that we did
not control for the effect of receiving attention from a car-
ing person. However, there are several arguments why a
placebo therapy would not be adequate for this study.BMC Psychiatry 2005, 5:39 http://www.biomedcentral.com/1471-244X/5/39
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Most importantly, it has been argued that the metaphor of
a placebo is conceptually inadequate in psychotherapy
research, considering the discussion on common factors
in psychotherapy [6]. It is therefore more appropriate to
examine the specific processes and mechanisms of ther-
apy by other means, such as the assessment of treatment
fidelity and the assessment of mediator variables that we
included in the design.
It may also be criticised that self-reports may be biased
because of expectancy or social desirability effects. How-
ever, for some mental health outcomes, such as self-
esteem, there is no alternative to self-reports. The main
outcome for this study will however be rated by a blind
assessor. Blinding of participants is not possible in psy-
chotherapy studies.
A final criticism might concern the broad inclusion crite-
ria. The study sample will be broad with regard to diag-
noses, but the main inclusion criterion will be unrelated
to diagnosis and well linked to an important clinical ques-
tion. As this will improve generalisability, this last limita-
tion can also as be regarded as one of the strengths of this
study.
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